Senior MSL, Lymphoma (Lacutamab) — Remote

Swedish Orphan Biovitrum AB (publ); Phoenix (AZ); Remote; USD 215,000 - 230,000; Full time

Benefits offered by this job

Competitive compensation

Generous time off

Conference attendance

Work-life balance

Collaborative culture

Impact for ultra-rare disease patients

Job summary

Swedish Orphan Biovitrum AB (publ) is seeking a Senior Medical Science Liaison, Lymphoma (Lacutamab) to join our US Medical Affairs team. This remote field-role supports CTCL scientific engagement across hematology, dermatology, and dermato-oncology, with a focus on lacutamab data and patient pathways.

You will build trusted relationships with HCPs, respond to scientific inquiries, and contribute to launch readiness and evidence generation while aligning with regulatory and compliance

Qualifications

• Accredited doctorate degree in a life-science, health-science, or basic-science discipline.
• At least 5 years of MSL experience in hematology/oncology.
• Experience in rare disease and/or product launch is highly preferred.
• Knowledge of CTCL and multidisciplinary care environment is an advantage.

Responsibilities

• Serve as a primary field-based scientific point of contact for Sobi Medical Affairs within your assigned geography.
• Develop and maintain relationships with key stakeholders involved in CTCL care.
• Exchange accurate, fair, balanced scientific information on CTCL and lacutamab.
• Identify high-quality field insights and inform adjustments to medical strategy and educational priorities.
• Support launch readiness and education activities at local, regional, and national levels.

Skills

Stakeholder engagement

Communication

Collaboration

Execution

Integrity and compliance

Patient focus

Education

Doctorate in life-science

Job description

Swedish Orphan Biovitrum AB (publ) is seeking a Senior Medical Science Liaison, Lymphoma (Lacutamab) to join our US Medical Affairs team. This remote field-role supports CTCL scientific engagement across hematology, dermatology, and dermato-oncology, with a focus on lacutamab data and patient pathways.

You will build trusted relationships with HCPs, respond to scientific inquiries, and contribute to launch readiness and evidence generation while aligning with regulatory and compliance